Incremental cost-effectiveness analysis for CUSUMGFR-based screening for chronic kidney disease, based on QALYs.
figure
posted on 2024-03-13, 17:26 authored by Reyhaneh Zafarnejad, Qiushi Chen, Paul M. GriffinAnnual universal screening starting at the age of 30 is the non-dominated screening policy, followed closely by screening the patients with diabetes.
(TIF)
History
Usage metrics
Keywords
total discounted disabilitysodium &# 8211probabilistic sensitivity analysesdirect health costsbasic blood testadjusted life years60 years ),influential model parameterscumulative sum statisticrecent treatment optionchronic kidney diseasetesting cost resultedpatients ’ awarenessconsidered four cusumckd progression rateuniversal annual screeningestimated incremental costdisease progressionincremental costmicrosimulation modelcumulative egfrtreatment regimendisease monitoringhighly costunited statesstatus quostarting agesimple requirementroutine screeningperformed onemajor complicationslifetime horizonidentifying patientsicer ).highest variabilityeasily incorporatedearly stagesclinical workflowclinical guidelinesckd using
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC